TABLE 1.
AD cases | Age‐matched controls | Cognitively healthy centenarians | |
---|---|---|---|
Sample size | 2281 | 3165 | 346 |
Age | 67.96 ± 9.84 | 62.57 ± 8.66 | 101.05 ± 2.51 |
Females (%) | 1265 (55%) | 1507 (48%) | 247 (71%) |
APOE ε2 (%) | 3% | 9% | 13% |
APOE ε4 (%) | 43% | 17% | 7% |
Note: Additional information about the cohorts used is available in Methods and Supplementary Methods (in supporting information) sections. Reference to the cohorts described in this table are: Holstege et al., 5 van der Flier and Scheltens, 17 Rademaker et al., 20 Hoogendijk et al.,21 Willemsen et al., 22 and Slot et al. 29 Age = age at onset for AD cases, age at study inclusion for age‐matched controls, and cognitively healthy centenarians.
Abbreviations: AD, Alzheimer's disease; APOE, apolipoprotein E.